Q16667 AF NFT

Cyclin-dependent kinase inhibitor 3

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiesozmtpvuqy7ve2h4s2ldp6argsecrmrqjh7zocomrho2s54ouku/metadata.json
IPFS of structure file: 
bafybeicd5jxfc5l3up4s47schneplzyklgqqzron3w6qvxaqqo7pxd5pei/AF-Q16667-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x89365364536602e20ca45Af31c26b1889b622007
First NFT owner address (bech32): 
genesis13ym9xeznvcpwyr9ytte3cf433zdkygq8lp5c0k
Current NFT ID #57171 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
57171
Accession (UniProt):
Q16667
Name::
Cyclin-dependent kinase inhibitor 3
Experimental Method:
Predicted structure
Sequence source:
HOMO SAPIENS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q16667 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q16667|CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens OX=9606 GN=CDKN3 PE=1 SV=1 MKPPSSIQTSEFDSSDEEPIEDEQTPIHISWLSLSRVNCSQFLGLCALPGCKFKDVRRNVQKDTEELKSCGIQDIFVFCTRGELSKYRVPNLLDLYQQCGIITHHHPIADGGTPDIASCCEIMEELTTCLKNYRKTLIHCYGGLGRSCLVAACLLLYLSDTISPEQAIDSLRDLRGSGAIQTIKQYNYLHEFRDKLAAHLSSRDSQSRSVSR